Ceribell to Participate in the 43rd Annual J.P. Morgan Healthcare Conference SUNNYVALE, Calif., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Ceribell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

Ceribell Appoints Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing —Ms. Rodenbush to lead hiring and talent development initiatives— —Mr. Price to focus on market development and penetration— SUNNYVALE, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) --...

Ceribell Reports Third Quarter 2024 Financial Results SUNNYVALE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

Ceribell Receives Authority to Operate from the U.S. Department of Veterans Affairs —Ceribell System stands to reduce costly ICU admissions and intra-facility patient transfers— —Military veterans face elevated risks of developing seizure disorders— SUNNYVALE, Calif., Nov. ...

Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum SUNNYVALE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...